AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Prodromes of Menstrual Staphylococcal Toxic Shock

Recruitingn/aAges 13 Years - 30 YearsFemaleHospices Civils de Lyon
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Menstrual staphylococcal toxic shock is a rare but severe disease, requiring intensive care in over 80% of cases. Menstrual staphylococcal toxic shock develops during the peri-menstrual period, in healthy young women colonized by a vaginal strain of Staphylococcus aureus secreting the Toxic shock syndrome toxin 1 (TSST-1) and not immune to it, in a favorable environment, i.e. wearing intravaginal menstrual protection (tampon, menstrual cup). The rarity of the syndrome, its polymorphous clinical presentation and the absence of a totally specific biological examination make menstrual staphylococcal toxic shock a difficult pathology to diagnose. The reference clinical criteria correspond to the advanced picture of multivisceral failure, making it possible to classify cases a posteriori, but contribute to diagnostic delay and lack sensitivity. Patient accounts suggest the presence of sympt

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria : +Case inclusion criteria: * Women between 13 and 30 years old inclusive * Clinical diagnosis of staphylococcal toxic shock syndrome: "confirmed" or "probable" according to Center Disease Control (CDC) criteria: The 5 CDC clinical criteria for menstrual Staphylococcal Toxic Shock are: * a fever above 39ยฐC, * arterial hypotension, * generalized scarlatiniform erythroderma * intense peeling of the palms or soles of the feet 7 to 14 days later, * and systemic manifestations (at least three): * Digestive: vomiting, diarrhea * Muscular: myalgia, increase in serum creatine phosphokinase * Hyperemia of the vaginal, oropharyngeal and conjunctival mucous membranes * Renal: hyperuricemia, hypercreatininemia, leukocyturia without urinary infection, * Hepatic: increase in transaminases * Hematological: thrombocytopenia (\< 100,000 platelets/mm3) * Neurological: apart from episodes of fever or hypotension such as disorientation or altered consciousness. In the presence of 4 criteria, the case is considered probable and 5 criteria as confirmed case. * Detection of S. aureus strain carrying Toxic shock syndrome toxin-1 (TSST1) on vaginal samples. * Onset of symptoms โ‰ค 72 hours before the start of menstruation and โ‰ฅ 72 hours after the end of menstruation. * Use during the last 3 cycles of vaginal protection: tampon or menstrual cup. +Control inclusion criteria: * Women between 13 and 30 years old inclusive * Presence of menstruation * Use of intimate periodic protection, tampon or menstrual cup, during the last 3 periods * No history of toxic menstrual shock Exclusion Criteria: * Non-menstruating women * Women protected by law * Women (or relatives) who oppose the study
๐Ÿ’Š

What it tests

  • Identification of symptoms of menstrual staphylococcal toxic shock in last three menstrual period
  • Identification of symptoms of menstrual in control patient in the last three menstrual period
๐Ÿ“

Where

1 site
Hopital Nord Croix Rousse
Lyon, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy